Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04892173
Title NBTXR3 With or Without Cetuximab in LA-HNSCC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Nanobiotix
Indications

hypopharynx cancer

oropharynx cancer

oral squamous cell carcinoma

supraglottis squamous cell carcinoma

Therapies

Cetuximab

NBTXR3

Age Groups: senior
Covered Countries USA | FRA | ESP | BEL


No variant requirements are available.